4/A//SEC Filing
Daniel Jeremy 4/A
Accession 0001493152-21-008784
CIK 0001591165other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 7:40 PM ET
Size
6.2 KB
Accession
0001493152-21-008784
Insider Transaction Report
Form 4/AAmended
H-CYTE, INC.HCYT
Daniel Jeremy
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-01+5,000,000→ 5,000,000 totalExercise: $0.07Exp: 2031-04-01→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]This amendment is being filed to amend the vesting period for such options granted to Mr. Daniel on April 1, 2021. On April 1, 2021, Hy-Cyte, Inc. (the "Company) issued to Jeremy Daniel options (the "Options") to purchase 5,000,000 shares of the Company's common stock at an exercise price of $0.07. The Options shall be exercisable with respect to 1,000,000 Option Shares immediately upon the grant thereof, 1,250,000 shares shall be exercisable on the twelve (12) month anniversary of the Date of Grant, and the remaining Option Shares shall be exercisable in 6.25% quarterly installments for the remaining 3 year period, in each case, so long as Mr. Daniel remains an employee of the Company or a subsidiary thereof on each such date.
Documents
Issuer
H-CYTE, INC.
CIK 0001591165
Entity typeother
Related Parties
1- filerCIK 0001767519
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 7:40 PM ET
- Size
- 6.2 KB